Importer of Controlled Substances; Notice of Application, 31049 [E9-15234]

Download as PDF Federal Register / Vol. 74, No. 123 / Monday, June 29, 2009 / Notices Charles Mikalian (312–886–2242)). During the public comment period, the Consent Decree may also be examined on the following Department of Justice Web site: https://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $20.50 (25 cents per page reproduction cost), for the consent decree alone, or in the amount of $158.00 (for the consent decree and all appendices) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. Maureen Katz, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E9–15306 Filed 6–26–09; 8:45 am] The proposed Agreement may be examined at the Region 9 Office of the United States Environmental Protection Agency, 75 Hawthorne Street, San Francisco, California 94105. During the public comment period, the proposed Agreement may also be examined on the following Department of Justice website: https://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the proposed Agreement may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $2.75 (25 cents per page reproduction cost) payable to the U.S. Treasury. Maureen Katz, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E9–15272 Filed 6–26–09; 8:45 am] BILLING CODE 4410–15–P BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration sroberts on PROD1PC70 with NOTICES Notice of Proposed Administrative Settlement Agreement and Order on Consent Under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) Importer of Controlled Substances; Notice of Application Notice is hereby given that on June 15, 2009, a proposed Settlement Agreement regarding the Asarco Hayden Plant Site in Hayden, Arizona was filed with the United States Bankruptcy Court for the Southern District of Texas in In re Asarco LLC, No. 05–21207 (Bankr. S.D. Tex.). The proposed Agreement, entered into by the United States and Asarco LLC, provides the U.S. Environmental Protection Agency an allowed general unsecured claim of $3.0 million for response costs incurred by EPA on or before May 27, 2008 at the Asarco Hayden Plant Site. The Department of Justice will receive comments relating to the proposed Agreement for a period of thirty (30) days from the date of this publication. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to In re Asarco LLC, DJ Ref. No. 90–11–3–08633. VerDate Nov<24>2008 19:07 Jun 26, 2009 Jkt 217001 Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with Title 21, Code of Federal Regulations (CFR), 1301.34(a), this is notice that on May 22, 2009, Noramco, Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by letter to the Drug Enforcement Administration (DEA) to be registered as an importer of Tapentadol (9780), a basic class of controlled substance listed in schedule II. The company plans to import an intermediate of the basic class listed for the bulk manufacture of Tapentadol which it will distribute to its customers. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic class of controlled substance PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 31049 may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than July 29, 2009. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: June 22, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15234 Filed 6–26–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Mine Safety and Health Administration Brookwood-Sago Mine Safety Grants AGENCY: Mine Safety and Health Administration, Labor. ACTION: Notice of funding and priorities for fiscal year 2009. SUMMARY: The U.S. Department of Labor, Mine Safety and Health Administration (MSHA), is making $500,000 available in grant funds in FY 2009 for educational and training programs to help identify, avoid, and prevent unsafe working conditions in and around mines. The focus of these grants for FY 2009 will be on training and training materials for mine emergency preparedness and haulage safety for mines. MSHA is expanding this grant opportunity to cover all mines, both surface and underground metal and nonmetal and coal mines. Applicants for the grants may be States E:\FR\FM\29JNN1.SGM 29JNN1

Agencies

[Federal Register Volume 74, Number 123 (Monday, June 29, 2009)]
[Notices]
[Page 31049]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15234]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this section to a bulk manufacturer of a 
controlled substance in schedule I or II, and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Title 21, Code of Federal Regulations 
(CFR), 1301.34(a), this is notice that on May 22, 2009, Noramco, Inc., 
Division of Ortho-McNeil, Inc., 1440 Olympic Drive, Athens, Georgia 
30601, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Tapentadol 
(9780), a basic class of controlled substance listed in schedule II.
    The company plans to import an intermediate of the basic class 
listed for the bulk manufacture of Tapentadol which it will distribute 
to its customers.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, VA 22152; and must be filed no later 
than July 29, 2009.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745-46), all 
applicants for registration to import a basic class of any controlled 
substances in schedule I or II are, and will continue to be, required 
to demonstrate to the Deputy Assistant Administrator, Office of 
Diversion Control, Drug Enforcement Administration, that the 
requirements for such registration pursuant to 21 U.S.C. 958(a); 21 
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are 
satisfied.

    Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15234 Filed 6-26-09; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.